Laura Stoppel
Known title: DirectorCIK: 0001865119
Associated companies
Transaction History
| ABOS | ▲ Buy | Grant | 35,500 | $0 | 6/3/2026 | View on chart |
| ABOS | ▲ Buy | Grant | 12,800 | $0 | 6/4/2025 | View on chart |
| ABOS | ▲ Buy | Grant | 35,500 | $0 | 6/3/2026 | View on chart |
| ABOS | ▲ Buy | Grant | 12,800 | $0 | 6/4/2025 | View on chart |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 27, 2026
Acumen Pharmaceuticals Featured in Alzheimer's Day Stock List
Acumen Pharmaceuticals was included in a Yahoo Finance article highlighting four Alzheimer's drug stocks to watch on World Alzheimer's Day. The mention serves as a reminder of the company's focus on neurodegenerative diseases, though the article does not report any new clinical data or corporate announcements. The stock is currently trading near its 52-week low, with an average analyst target of $7.60.
Acumen Pharmaceuticals Featured in Alzheimer's Day Stock List. Acumen Pharmaceuticals was included in a Yahoo Finance article highlighting four Alzheimer's drug stocks to watch on World Alzheimer's Day. The mention serves as a reminder of the company's focus on neurodegenerative diseases, though the article does not report any new clinical data or corporate announcements. The stock is currently trading near its 52-week low, with an average analyst target of $7.60.